Another study also reported that TBK1 inhibitor greatly delayed the onset and decreased the severity of experimental autoimmune encephalomyelitis (EAE), and even suppressed the relapse of EAE [75]. Here, TBK1 is linked to experimental autoimmune encephalomyelitis.